Could Viking Therapeutics Next: Will It Challenge Lilly?
The race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
Explore strategies to prevent wasting your credit card benefits and maximize your rewards potential.
14,940 articlesThe race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
A new AI platform launch aims to empower independent brokerages to stay independent, compete scale, and win at scale ...
A boutique fund revealed a sizable stake in a hotel stock, signaling interest in the sector’s recovery. Here’s a prac...
A renewed debate over gifting beyond required minimum distributions challenges retirees to balance tax costs with lon...
Chevron sits at the heart of today’s energy debate: steady production, looming supply gaps, and the question every in...
A major investment bank just signaled a powerful vote of confidence in Lilly's GLP-1 strategy. This article breaks do...
A rapid-growth software startup markets a scrolling-based monetization model and seeks pre-IPO investors at $0.50 a s...
A 2026 market backdrop prompts a fresh look at when to retire early. A saver chasing seven figures weighs the 4% rule...
The idea of a bargain in the cruise sector is enticing, but cheap can be risky. This article breaks down how to judge...
With $100 to deploy, traders face a crowded crypto menu. This article breaks down the options, highlighting the best ...
Two affordable biotech names are drawing attention for potential low-beta growth as AI-driven tools reshape pipelines...
AI-powered data centers are fueling a breakout in infrastructure plays. They offer a viable alternative to chip stock...